Cell Signaling & Oncology
The signaling pathways controlling cell growth and differentiation are almost invariably altered in cancer. During the course of tumor progression, cancer cells acquire a number of characteristic alterations. These include the capacities to proliferate independently of exogenous growth-promoting or growth-inhibitory signals, to invade surrounding tissues and metastasize to distant sites, to elicit an angiogenic response, and to evade mechanisms that limit cell proliferation, such as apoptosis and replicative senescence. These properties reflect alterations in the cellular signaling pathways that in normal cells control cell proliferation, motility, and survival. These interconnected pathways are being deciphered, but understanding the alterations that lead to cancer and correcting them is a substantial challenge. Among the key pathways are those controlling cell proliferation, which coordinate a response to the cellular environment, with the mTOR kinase as a critical node. Tumour development is influenced by infections and inflammation, and the complex role of the nuclear factor-B transcription factors is being unravelled. Expansion of tumour cells depends on nutrient supply and vascularization, which is orchestrated by the transcription factor known as HIF. And the metastatic spread of primary tumours to other organs is facilitated by many signaling pathways[1],[2].
Cell Signaling and Oncology products Library
For your convenience, you can order a library of all of our Cell Signaling and Oncology research related products. Make your personal library by cherry picking products of your interest from our comprehensive list (>800 products), or order all together not to miss any. The libraries will be shipped as 10 mM solutions (in DMSO, 250 µL of each selected Axon Ligand™) on a 96-well microtiter plate with a clear map of its contents.
Simply download our comprehensive list of epigenetics products below (Microsoft Excel (.xls)), check the products to be included, and return your list to order the library of your preference.
![]() |
|
[1] A. Eccleston, R. Dhand. Signalling in cancer. Nature 441, 423, editorial note
[2] G.S. Martin. Cell signaling and cancer. Cancer Cell. 2003 Sep;4(3):167-74.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
2169 | VX 661 | Corrector of the cystic fibrosis transmembrane conductance regulator (CFTR) | €80.00 | |
3410 | UTL-5g | TNFα modulator | €120.00 | |
2326 | Temozolomide | DNA methylating agent; apoptosis inducer | €50.00 | |
3252 | Tamoxifen | Selective estrogen receptor modulator (SERM) | €50.00 | |
2487 | Silibinin | Natural flavonolignan, cytoprotectant, antioxidant, and antihepatotoxic agent | €40.00 | |
2544 | S3QEL 2 | Suppressor of superoxide production from mitochondrial complex III | €60.00 | |
2868 | Roquinimex | Immunomodulator | €125.00 | |
2999 | RCGD 423 | gp130 signalling modulator | €95.00 | |
1823 | Pregabalin | Reduces synaptic signaling by binding to α2δ subunits | €90.00 | |
4045 | Nimustine hydrochloride | Water-soluble DNA alkylating agent | €90.00 | |
2322 | Neuropathiazol | Selective inducer of neural differentiation of adult hippocampal neural progenitor cells (NPCs). | €130.00 | |
2327 | NEO 212 | DNA alkylating agent; chemotherapeutic | €110.00 | |
1967 | GW 791343 hydrochloride | P2X7 receptor antagonist and allosteric modulator | Inquire | |
2355 | FPH 2 | Proliferation inducer of mature human primary hepatocytes | €110.00 | |
2318 | FC 99 hydrochloride | Inhibitor of TLR3 expression and inflammatory responses. | €95.00 | |
1825 | Erastin | VDAC2 modulator | €90.00 | |
2707 | Endoxifen hydrochloride | Selective estrogen receptor modulator (SERM) | €130.00 | |
2190 | Endoxifen | Selective estrogen receptor modulator (SERM) | €125.00 | |
2382 | ELN 484228 | α-Synuclein modulator and potential therapeutic for Parkinson’s disease | €75.00 | |
3715 | E-7386 | CBP/beta-catenin modulator | Inquire | |
1935 | DiMNF | Selective aryl hydrocarbon receptor modulator (SAhRM) | €105.00 | |
3459 | Dacarbazine | DNA alkylating agent; antineoplastic agent | €50.00 | |
2455 | CU-T12-9 | Selective TLR1/TLR2 agonist that facilitates the TLR1/2 complex formation | €120.00 | |
1763 | CoPo 22 | Modulator of CFTR (δ-F508 Selective) | €120.00 | |
3650 | Clomiphene citrate | Selective estrogen receptor modulator (SERM) | €50.00 | |
2645 | CC-885 | Cereblon (CRBN) modulator with potent anti-tumour activity | €120.00 | |
1748 | Bazedoxifene hydrochloride | Selective estrogen receptor modulator (SERM) | €70.00 | |
2051 | Bazedoxifene acetate | Selective estrogen receptor modulator (SERM) | €80.00 | |
1675 | Asoprisnil | Progesterone receptor (PR) modulator | €130.00 | |
2221 | (Z)-Endoxifen | The more active (Z)-isomer of Endoxifen (SERM; Axon 2190) | €150.00 |